Abstract:The main mol-ecule of the title solvate, C(33)H(30)N(2)O(10)·CH(3)OH, is a new anti-tumor agent, which shows cytotoxicity against MDR cancer cell lines. It has been synthesized by coupling 4β-amino-podophyllotoxin with (5-meth-oxy-1H-indol-3-yl)glyoxyl chloride and structurally characterized. There are two crystallographically independent mol-ecules in the asymmetric unit, which differ in the dihedral angles between the aromatic rings. The dihedral angles between the benzene ring of the benzo[d][1,3]dioxole and the benzene ring of the 5-meth-oxy-1H-indole are 85.08 (3) and 76.88 (3)° and reflect the main conformational difference between the two independent mol-ecules. The asymmetric unit is completed with two methanol solvent mol-ecules, one of which is disordered over two positions, with occupancies close to 0.5.

(5Α,8α,9β,11s)-5,7,8,9-tetrahydro-11-(fluoromethyl)-9-(3,4,5-trimethoxyphenyl)-5,8-methano-1,3-dioxolo[4,5-h][2]benzoxepin

4-Des-oxy-4β-[(5-meth-oxy-1H-indol-3-yl)oxalylamino]podophyllotoxin methanol solvate.

Synthesis and Crystal Structure Characterization of (1R,2R,3R,5S)-3-(3-chlorophenyl)-1-hydroxy-2-methyl-6-phenyl-8-oxa-6-azabicyclo[3.2.1]octan-7-one

(5Ar,8ar,9r)-9-(3,4,5-trimethoxyphenyl)5a,6,8a,9-tetrahydrofuro[3 ',4 ': 6,7]Naphtho[2,3-D][1,3]dioxole-5,8-dione

(1S,4aR,5S,6S,8aR*)-3-Benzyl-1-methyl-5,6-diphenyl-3,4,4a,5,6,8a-hexa-hydro-1H-2,3-benzoxazin-4-one.

(1<i>S</i>,4a<i>R</i>,5<i>S</i>,6<i>S</i>,8a<i>R</i>*)-3-Benzyl-1-methyl-5,6-diphenyl-3,4,4a,5,6,8a-hexahydro-1<i>H</i>-2,3-benzoxazin-4-one

1-(4-Fluoro-phen-yl)-3-hydr-oxy-3-phenyl-prop-2-en-1-one.

N-Cyclo-hexyl-5H,7H-13,15-dimethyl-9-nitro-5-oxophenanthrido[4,4a,5-bc][1,4]benzoxazepine-7-carboxamide.

Ethyl (4a<i>R</i>,7<i>S</i>,8<i>S</i>,8a<i>S</i>)-1-oxo-7-phenyl-3,4,4a,7,8,8a-hexahydro-1<i>H</i>-isochromene-8-carboxylate

Dimethyl 2-(4-Fluorophenyl)-3-(methylamino)-furan-4,5-dicarboxylate

(1′S,2′s,5′r)-3-(2-bromopropionyl)-2′-isopropyl-5′-methylspiro[2h-1,3-benzoxazine-2,1′-cyclohexan]-4(3h)-one

(1S,3as,4s,7as)-Ethyl 1-Benzyl-2-(4-methoxybenzyl)-6,7-dimethyl-3-oxo-2,3,3a,4,5,7a-hexahydro-1h-isoindole-4-carboxylate Dichloromethane Monosolvate

1-(4-Fluoro-phen-yl)-5-(4-methoxy-phen-yl)pyrazolidin-3-one.

(E)-4-chloro-2-{[4-(3,5-dichloro-pyridin-2-yl-oxy)phenyl-imino]-meth-yl}phenol.

(5R,6r)-Methyl 6-Methyl-2-phenyl-5,6dihydro-4h-1,3-oxazine-5-carboxylate

9,10,11,12-Tetrachloro-12b-hydroxy-12c-phenyl-1,2,3,3a,5,6,12b,12c-octahydro-8h-cyclopenta[6,7][1,4]oxazepino[5,4-a]isoindol-8-one

5,7-Bis(benzyloxy)-4h-benzopyran-4-one

Ethyl (2s,4r)-4-(4-Bromophenyl)-2-Hydroxy-5,10-Dioxo-3,4,5,10-Tetrahydro-2h-Be Nzo[G]Chromene-2-Carboxylate

6-(4-Chlorophenyl)-3-methyl-2,4a-diphenyl-5,6-dihydro-1h,4ah-1,3-oxazino[2,3-d][1,5]benzothiazepin-1-one

4,5-Diazafluoren-9-ol

3-(4-Tert-butylphenyl)-1-(4-fluorophenyl)-3-hydroxyprop-2-en-1-one